Ipilimumab vs Technetium Tc 99M Albumin Aggregated
Ipilimumab vs Technetium Tc 99M Albumin Aggregated: Overview
This comparison examines the pharmacological differences between Ipilimumab and Technetium Tc 99M Albumin Aggregated.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Technetium Tc 99M Albumin Aggregated — Protein.